Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Guided Therapeutics (GTHP) Interest Income - Total (2023 - 2024)

Historic Interest Income - Total for Guided Therapeutics (GTHP) over the last 2 years, with Q1 2024 value amounting to $3000.0.

  • Guided Therapeutics' Interest Income - Total changed N/A to $3000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $3000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $3000.0 for FY2024, which is 5000.0% down from last year.
  • According to the latest figures from Q1 2024, Guided Therapeutics' Interest Income - Total is $3000.0.
  • Over the past 5 years, Guided Therapeutics' Interest Income - Total peaked at $6000.0 during Q4 2023, and registered a low of $3000.0 during Q1 2024.